Jose Octavio Filho - Jul 12, 2021 Form 3 Insider Report for Monopar Therapeutics (MNPR)

Role
Chief Medical Officer
Signature
/s/ Kim R. Tsuchimoto, Attorney-in-Fact
Stock symbol
MNPR
Transactions as of
Jul 12, 2021
Transactions value $
$0
Form type
3
Date filed
7/12/2021, 06:05 PM

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney